SCHEMBL9684632

SCHEMBL9684632

CNCCCN1C2c3ccccc3C1c1sccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 6/20 0.36
HTR2A P28223 6/20 0.36
HRH1 P35367 6/20 0.36
CYP3A4 P08684 5/20 0.36
CYP2D6 P10635 4/20 0.36
SLC6A3 Q01959 4/20 0.36
KDM4E B2RXH2 4/20 0.36
CHRM2 P08172 3/20 0.36
CHRM1 P11229 3/20 0.36
DRD2 P14416 3/20 0.36
ADRA2B P18089 3/20 0.36
ADRA2C P18825 3/20 0.36
CHRM3 P20309 3/20 0.36
HTR2C P28335 3/20 0.36
ADRA1A P35348 3/20 0.36
DRD3 P35462 3/20 0.36
THPO P40225 3/20 0.36
HTR2B P41595 3/20 0.36
CACNA1B Q00975 3/20 0.36
KCNH2 Q12809 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9683465 0.92 CARM1 (0.33) SLC6A2HTR2AHRH1CYP3A4CYP2D6
SCHEMBL9684167 0.81 ALDH1A1 (0.31) HTT
SCHEMBL9684133 0.81 CYP2D6 (0.38) SLC6A2HTR2AHRH1CYP2D6SLC6A3
SCHEMBL9683517 0.78 HTT (0.30) HTT
SCHEMBL9683453 0.78 OPRM1 (0.35) SLC6A2SLC6A3HTTSLC6A4OPRM1
SCHEMBL9683476 0.77 KDM1A (0.36) SLC6A2HTR2AHRH1CYP2D6KDM4E
SCHEMBL9683338 0.75 POLB (0.34) CYP3A4CYP2D6KDM4ETP53MEN1
SCHEMBL9682581 0.72 HTT (0.35) SLC6A2SLC6A3KDM4EHTTSLC6A4
SCHEMBL9684243 0.72 CHRM2 (0.37) CHRM2TP53HSD17B10KMT2AMAPK1
SCHEMBL9684281 0.71 OPRM1 (0.37) OPRM1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0475187-A1 Naphthothiophenimines for treating neuronal disorders caused by ischemia BRISTOL-MYERS SQUIBB COMPANY (US) 1992-03-18 EP disclosed
US-5064831-A N-methyl-d-aspartate receptor antagonist BRISTOL-MYERS SQUIBB CO. (US) 1991-11-12 US disclosed